Related Experiment Videos
Expanded drug access: etravirine (formerly TMC-125)
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2014
Same author
A review of the toxicity of HIV medications.
Journal of medical toxicology : official journal of the American College of Medical Toxicology·2013
Same author
Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth.
The Pediatric infectious disease journal·2012
Same author
Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
AIDS (London, England)·2012
Same author
Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012
Same journal
Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). CD4 lymphocyte depletion: where have all the cells gone?
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007
Same journal
Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Viral hepatitis co-infection in HIV.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007
Same journal
Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007
Same journal
Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Management of treatment-naïve patients.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007
Same journal
Expanded access drug profile: raltegravir (RAL, MK-0518).
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007
Same journal
Drug profile: telbivudine (Tyzeka).
The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2007